Covance Receives MHRA Accreditation for UK Facility

August 3, 2009

Company News Release

July 30, 2009, Princeton, NJ

The Medicines and Healthcare products Regulatory Agency (MHRA) awarded Covance's (Princeton, NJ) clinical research unit in Leeds, UK, where the company conducts first-in-human studies, with standard and supplementary accreditation for the conduct of clinical pharmacology in Europe. The MHRA accreditation, which is voluntary, ensures that research facilities and studies meet industry standards for patient safety in early clinical development.

"Covance delivers the highest level of data quality and safety for first-in-human trials, which is confirmed by the accreditation," said Rob Aspbury, MD, Covance's managing director of clinical research services, in a press release.

In order to receive this type of accreditation, formal inspections are performed by MHRA, which is based in London.

Related Content:

News